Locally Recurrent Colorectal Cancer
2 clinical trials · Condition
◉ Watch Locally Recurrent Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer (NCT06881537) | Shanghai Changzheng Hospital | 2024-06-01 |
| Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer (NCT06114420) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-01-30 |
Track Locally Recurrent Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.